Abstract
Data on non-vitamin K antagonist oral anticoagulants (NOACs) in transcatheter aortic valve replacement (TAVR) patients are controversial. In patients ......
小提示：本篇文献需要登录阅读全文，点击跳转登录
Full Text Link
